Clinical Trials Browser

Unknown × INDUSTRY × duvelisib × Clear all

NCT04707079 2021-01-13

A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma

Phase 2 Unknown

Lymphoma, Follicular